BioPlus Acquisition Corp.
BIOSNASDAQFinancial Services
$10.80
$-0.01(-0.05%)
Market Cap$209072163
P/E Ratio—
52W High$11.68
52W Low$10.12
BioPlus Acquisition Corp.（BIOS）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BIOS · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2022-12 | 2021-12 | 2018-12 | 2017-12 | 2016-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.00B | ($0.00B) | ($0.05B) | ($0.06B) | ($0.04B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.02B | $0.03B | $0.02B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | $0.00B | ($0.07B) | ($0.02B) | $0.04B |
| Net Cash from Operations | ($0.00B) | ($0.00B) | ($0.02B) | ($0.00B) | ($0.04B) |
| Investing Activities | |||||
| Capital Expenditure | $0.00B | $0.00B | ($0.01B) | ($0.01B) | ($0.01B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | $0.00B | ($0.00B) | ($0.01B) | ($0.01B) | ($0.07B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.00B) | $0.02B | $0.08B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.00B | $0.00B | $0.01B | $0.04B | $0.11B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.00B) | ($0.00B) | ($0.03B) | ($0.01B) | ($0.05B) |
| FCF Margin %(computed) | — | — | -4.79% | -1.16% | -5.60% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解BioPlus Acquisition Corp.
关于BioPlus Acquisition Corp.（BIOS）现金流量表
BioPlus Acquisition Corp. 2022财年经营活动现金流($0.00B)，自由现金流($0.00B)（FCF利润率—），资本支出$0.00B。
常见问题
BIOS · 4 问BioPlus Acquisition Corp. 2022财年自由现金流($0.00B)，同比down81798.5%。
BIOS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10